AC Immune
Clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases
Total raised
€77M
€76,545,455
Funding rounds
3
Investors
0
distinct backers
Active since
2005-04
latest 2016-04
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood24
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood19
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €30M+ raised
- ▲ 23y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Series D+ | €40M | — | View deal → |
| 2014-01-01 | Series D+ | €18M | — | View deal → |
| 2005-05-01 | Series B | €19M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy